Serum Sclerostin in Hepatitis C Virus Infected Patients

BACKGROUND: Sclerostin inhibits osteoblast functions, differentiations, and survival rates. As an endogenous inhibitor of the Wnt/β-catenin pathway, the sclerostin should be related to decreased bone masses, although several studies indicate opposite results. In addition, it may be related to insuli...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: González-Reimers, Emilio, López-Prieto, Javier, Pelazas-González, Ricardo, Alemán-Valls, M.Remedios, José de la Vega-Prieto, María, Jorge-Ripper, Carlos, Durán-Castellón, M. Carmen, Santolaria-Fernández, F
Format: Artigo
Jezik:Inglês
Izdano: The Korean Society for Bone and Mineral Research 2014
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3970296/
https://ncbi.nlm.nih.gov/pubmed/24707469
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.11005/jbm.2014.21.1.69
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki